N4 Pharma Plc (FRA:0GO)
Germany
· Delayed Price · Currency is EUR 0.0010
0.00 (0.00%)
At close: Dec 4, 2025
N4 Pharma Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Cash & Equivalents | 1.73 | 0.63 | 1.03 | 1.92 | 1.78 | 3.56 | Upgrade
|
| Cash & Short-Term Investments | 1.73 | 0.63 | 1.03 | 1.92 | 1.78 | 3.56 | Upgrade
|
| Cash Growth | 43.37% | -39.05% | -46.49% | 7.60% | -49.83% | 268.17% | Upgrade
|
| Other Receivables | - | 0.13 | 0.18 | 0.21 | 0.55 | 0.25 | Upgrade
|
| Receivables | 0.12 | 0.13 | 0.18 | 0.21 | 0.55 | 0.25 | Upgrade
|
| Prepaid Expenses | - | 0.02 | 0.01 | 0.04 | 0.01 | 0.02 | Upgrade
|
| Total Current Assets | 1.85 | 0.78 | 1.21 | 2.17 | 2.34 | 3.83 | Upgrade
|
| Goodwill | - | - | 0.06 | - | - | - | Upgrade
|
| Total Assets | 1.85 | 0.78 | 1.28 | 2.17 | 2.34 | 3.83 | Upgrade
|
| Accounts Payable | 0.03 | 0.02 | 0.02 | 0.04 | 0.18 | 0.12 | Upgrade
|
| Accrued Expenses | 0.05 | 0.1 | 0.06 | 0.04 | 0.03 | 0.03 | Upgrade
|
| Other Current Liabilities | - | 0.01 | 0.01 | 0 | 0 | 0.03 | Upgrade
|
| Total Current Liabilities | 0.08 | 0.12 | 0.08 | 0.08 | 0.21 | 0.17 | Upgrade
|
| Total Liabilities | 0.08 | 0.12 | 0.08 | 0.08 | 0.21 | 0.17 | Upgrade
|
| Common Stock | 3.33 | 1.58 | 1.08 | 0.94 | 0.72 | 0.72 | Upgrade
|
| Additional Paid-In Capital | 14.74 | 14.94 | 14.87 | 14.7 | 13.95 | 13.95 | Upgrade
|
| Retained Earnings | -10.9 | -10.4 | -9.34 | -8.06 | -7.03 | -5.49 | Upgrade
|
| Comprehensive Income & Other | -5.4 | -5.47 | -5.48 | -5.48 | -5.51 | -5.52 | Upgrade
|
| Total Common Equity | 1.77 | 0.65 | 1.13 | 2.09 | 2.13 | 3.66 | Upgrade
|
| Minority Interest | 0 | 0 | 0.07 | - | - | - | Upgrade
|
| Shareholders' Equity | 1.77 | 0.65 | 1.19 | 2.09 | 2.13 | 3.66 | Upgrade
|
| Total Liabilities & Equity | 1.85 | 0.78 | 1.28 | 2.17 | 2.34 | 3.83 | Upgrade
|
| Net Cash (Debt) | 1.73 | 0.63 | 1.03 | 1.92 | 1.78 | 3.56 | Upgrade
|
| Net Cash Growth | 43.37% | -39.05% | -46.49% | 7.60% | -49.83% | 274.37% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | Upgrade
|
| Filing Date Shares Outstanding | 576.55 | 394.78 | 268.78 | 233.78 | 181.08 | 181.08 | Upgrade
|
| Total Common Shares Outstanding | 576.55 | 394.78 | 268.78 | 233.78 | 181.08 | 181.08 | Upgrade
|
| Working Capital | 1.77 | 0.65 | 1.13 | 2.09 | 2.13 | 3.66 | Upgrade
|
| Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Tangible Book Value | 1.77 | 0.65 | 1.07 | 2.09 | 2.13 | 3.66 | Upgrade
|
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.